About Check-Cap
Check-Cap is a company based in Haifa (Israel) founded in 2005. Check-Cap has raised $9.88 million across 15 funding rounds from investors including GE Healthcare, General Electric and Fosun Pharmaceutical. Check-Cap offers products and services including C-Scan System. Check-Cap operates in a competitive market with competitors including IGM Biosciences, New Element Medicine, Zymedi, Brenus Pharma and Promis Diagnostics, among others.
- Headquarter Haifa, Israel
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Check-Cap Ltd.
-
Annual Revenue
Not available
-
Net Profit
-$25.15 M (USD)-43.15as on Dec 31, 2024
-
EBITDA
-$9.3 M (USD)47.3as on Dec 31, 2024
-
Total Equity Funding
$9.88 M (USD)
in 15 rounds
-
Latest Funding Round
$9.63 M (USD), Post-IPO
Jul 23, 2020
-
Investors
GE Healthcare
& 7 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Check-Cap
Check-Cap is a publicly listed company on the NASDAQ with ticker symbol CHEK in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Check-Cap
Check-Cap offers a comprehensive portfolio of products and services, including C-Scan System.
Preparation-free test for detecting precancerous polyps in cancer screening
People of Check-Cap
Unlock access to complete
Funding Insights of Check-Cap
Check-Cap has successfully raised a total of $9.88M across 15 strategic funding rounds. The most recent funding activity was a Post-IPO round of $9.63 million completed in July 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Check-Cap
Check-Cap has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include GE Healthcare, General Electric and Fosun Pharmaceutical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pontifax Venture Capital is focused on life sciences investments.
|
Locked | Locked | Locked | |
|
Investments are directed toward Israeli technology startups by Docor.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Check-Cap
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Check-Cap
Investment portfolio details for Check-Cap
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Check-Cap
Detailed financials for Check-Cap
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Check-Cap Comparisons
Peer comparison for Check-Cap
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Check-Cap
Check-Cap operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as IGM Biosciences, New Element Medicine, Zymedi, Brenus Pharma and Promis Diagnostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibodies for cancer and infectious disease treatments are developed.
|
|
| Locked | Locked | Locked |
Drugs for cancer and metabolic diseases are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for multiple diseases are developed using Aminoacyl-tRNA Synthetase technology.
|
|
| Locked | Locked | Locked |
Immunotherapy for cancer treatment is developed by Brenus Pharma.
|
|
| Locked | Locked | Locked |
Non-invasive diagnostics for colorectal cancer screening are developed.
|
Detailed competitors of Check-Cap
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Check-Cap
Complete news archive for Check-Cap
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Check-Cap
Check-Cap was founded in 2005 and raised its 1st funding round 6 years after it was founded.
Check-Cap is headquartered in Haifa, Israel. It is registered at Haifa, Haifa District, Israel.
Check-Cap is a funded company, having raised a total of $9.88M across 15 funding rounds to date.
Check-Cap was founded in 2005 in Haifa, Israel, and operates in the medical technology sector. Non-invasive imaging capsules are developed for colorectal cancer screening, eliminating the need for bowel preparation or invasive procedures. Polyps are detected with high sensitivity through structural examinations. The technology has been validated in animal studies, supporting early cancer detection efforts.
Check-Cap's top competitors include IGM Biosciences, Zymedi and Brenus Pharma.
Check-Cap offers C-Scan System.
Yes, Check-Cap is publicly traded on NASDAQ under the ticker symbol CHEK.
Check-Cap has 8 investors. Key investors include GE Healthcare, General Electric, Fosun Pharmaceutical, Ministry of Economy and industry, and Pontifax Venture Capital.
The ticker symbol of Check-Cap is CHEK on NASDAQ.